 Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector 
              Mr. Tapan Patel- Senior Analyst (Commodities), HDFC securities
Gold prices traded steady on Tuesday with international spot gold prices held the steady trading range near $1736 after witnessing decline in Monday night.
Gold futures at MCX for June traded with marginal gain of Rs. 55 to Rs. 46710 despite of stronger rupee which appreciated by 27 paisa against the dollar during the day.
Gold prices witnessed selling from Monday evening session on positive global cues on vaccine hopes. The risk on sentiments pushed equity indices higher which led to selling in gold. Gold prices pared precious gains after US company Moderna reported successful phase 1 trial for coronavirus vaccine.
However, economic growth concerns and tensions between US and China may limit downside in gold prices.
We expect prices to trade sideways to up with MCX Gold June support at Rs. 46300, resistance at Rs. 46900.